Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.27
0.01 (0.10%)
At close: Aug 21, 2025, 3:59 PM
10.28
0.10%
After-hours: Aug 21, 2025, 04:00 PM EDT

Drugs Made In America Acquisition Ordinary Shares Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
Revenue
n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a
Operating Income
-131.92K -330.93K -279 -144.93K -54.93
Interest Income
2.42M 1.59M n/a n/a n/a
Pretax Income
2.29M 1.25M -279 -144.93K -54.93
Net Income
2.29M 1.25M -279 -144.93K -54.93
Selling & General & Admin
131.92K 330.93K 279.88 144.93K 54.93
Research & Development
n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
131.92K 330.93K 279.88 144.93K 54.93
Interest Expense
n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
131.92K 330.93K 279.88 144.93K 54.93
Income Tax Expense
n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
33.52M 9.61K 8.57K 8.57K 8.57K
Shares Outstanding (Diluted)
33.52M 25.51K 8.57K 8.57K 8.57K
EPS (Basic)
0.07 130.51 -0.03 -0.01 -0.01
EPS (Diluted)
0.07 49.18 -0.03 -0.01 -0.01
EBITDA
-131.92K -330.93K n/a -144.93K n/a
EBIT
-131.92K -330.93K -279 -144.93K -54.93
Depreciation & Amortization
n/a n/a 279.88 n/a 54.93